Ken Griffin Lifevantage Corp Call Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$5.51 - $13.01 $144,362 - $340,862	26,200 New	26,200 $316,000
Q4 2023 Feb 14, 2024	SELL	$4.38 - $8.25 $13,578 - $25,575	-3,100 Reduced 24.8%	9,400 $56,000
Q3 2023 Nov 14, 2023	BUY	$4.22 - $7.51 $39,668 - $70,594	9,400 Added 303.23%	12,500 $80,000
Q2 2023 Aug 14, 2023	BUY	$3.04 - $5.5 $2,736 - $4,950	900 Added 40.91%	3,100 $13,000
Q1 2023 May 15, 2023	BUY	$3.26 - $4.0 $3,260 - $4,000	1,000 Added 83.33%	2,200 $7,000
Q4 2022 Feb 14, 2023	BUY	$3.63 - $4.03 $4,356 - $4,836	1,200 New	1,200 $4,000

3.85M

43.5K

2.3K

Ticker LFVN
Exchange NASDAQ
Sector Consumer Defensive
Industry Packaged Foods
Shares Outstandng 12,560,000
Market Cap $174M
Description
LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.